Edit

https://syntiron.com/
Last activity: 09.02.2024
Categories: DevelopmentFinTech
Babies at risk for neonatal sepsis are too young to be immunized, so Alloy-EK would be administered to expectant mothers to protect their infants. Administering the vaccine to pregnant mothers may simultaneously reduce the risk of infections in mothers that are caused by the same bacteria. Current Development Stage: Lead optimization CARB-X Investment: US$1.7 million Initial CARB-X Investment Date: January 18, 2024
Mentions
2
Location: United States, Minnesota, Saint Paul

Investors 1

DateNameWebsite
09.02.2024CARB-Xcarb-x.org

Mentions in press and media 2

DateTitleDescriptionSource
16.12.2009Syntiron scores major vaccine deal with Sanofi PasteurPromoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis h...medcitynew...
-Syntiron scores major vaccine deal with Sanofi PasteurST. PAUL, Minnesota–Syntiron LLC, a biotech start-up, has signed a $149 million licensing deal with ...medcitynew...

Reviews 0

Sign up to leave a review

Sign up Log In